Equipoise nejm

(345)   Breast Cancer International Research Group. BCIRG 006: Multicenter phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC–>T) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (Herceptin®) (AC–>TH) and with docetaxel, carboplatin and trastuzumab (TCH) in the adjuvant treatment of node positive and high risk node negative patients with operable breast cancer containing the HER2 alteration [protocol]. Version 5 (June 27, 2008). [Cited 2012 Sept 25]. Available from: http:///doi/full//NEJMoa0910383

Equipoise nejm

equipoise nejm

Media:

equipoise nejmequipoise nejm

http://buy-steroids.org